Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 2/20 | 0.31 |
| ▸ | FGF2 | P09038 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16263233 | 0.89 | F10 (0.35) | FGF1F10 | |
| SCHEMBL19677568 | 0.84 | F10 (0.41) | FGF1FGF2F10 | |
| SCHEMBL19677566 | 0.83 | BDNF (0.38) | F10 | |
| SCHEMBL16263232 | 0.83 | F10 (0.33) | FGF1F10 | |
| SCHEMBL16263230 | 0.81 | AMY2A (0.34) | FGF1F10 | |
| SCHEMBL19678405 | 0.80 | F10 (0.33) | FGF1FGF2F10 | |
| SCHEMBL19677572 | 0.76 | F10 (0.43) | FGF1FGF2F10 | |
| SCHEMBL19677573 | 0.72 | AMY2A (0.35) | F10 | |
| SCHEMBL14977885 | 0.69 | F10 (0.33) | F10 | |
| SCHEMBL19677570 | 0.69 | LGALS3 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140349962-A1 | RAPID TWO-STEP SYNTHESIS OF ANTI-COAGULANTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140349962-A1 | RAPID TWO-STEP SYNTHESIS OF ANTI-COAGULANTS | HPSE, SERPINC1, HPN | FGF1 2110/4885FGF2 841/4885F10 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.